US Stock MarketDetailed Quotes
QNTM Quantum BioPharma
- 4.550
- -0.440-8.82%
Close Nov 27 16:00 ET
- 4.785
- +0.235+5.16%
Post 20:01 ET
8.73MMarket Cap-329P/E (TTM)
4.980High4.380Low118.42KVolume4.980Open4.990Pre Close541.97KTurnover7.43%Turnover RatioLossP/E (Static)1.92MShares70.85052wk High0.54P/B7.26MFloat Cap3.50052wk Low--Dividend TTM1.59MShs Float910.000Historical High--Div YieldTTM12.02%Amplitude3.500Historical Low4.576Avg Price1Lot Size
Quantum BioPharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 45.48%4.07M | -36.45%3.47M | -75.77%2.25M | -28.65%19.57M | -69.83%2.01M | -61.40%2.8M | -25.89%5.46M | 57.63%9.3M | -18.71%27.43M | 8.84%6.66M |
| Selling and administrative expenses | 19.42%3.21M | -11.22%2.44M | -66.32%1.97M | -17.37%13.2M | -31.70%1.92M | -36.67%2.69M | -43.13%2.74M | 51.71%5.86M | -31.62%15.98M | -32.51%2.81M |
| -General and administrative expense | 19.42%3.21M | -11.22%2.44M | -66.32%1.97M | -17.37%13.2M | -31.70%1.92M | -36.67%2.69M | -43.13%2.74M | 51.71%5.86M | -31.62%15.98M | -32.51%2.81M |
| Research and development costs | 2,358.00%744.8K | -44.24%897.99K | -93.07%160.26K | -44.16%3.86M | -101.11%-29.96K | -101.77%-32.99K | 14.05%1.61M | 146.69%2.31M | 9.21%6.91M | 216.16%2.69M |
| Depreciation amortization depletion | -17.71%120.81K | -87.64%136.81K | -89.37%120.14K | -44.76%2.51M | -89.44%122.22K | -87.19%146.81K | -2.21%1.11M | 2.62%1.13M | 12.16%4.54M | 4.54%1.16M |
| -Depreciation and amortization | -17.71%120.81K | -87.64%136.81K | -89.37%120.14K | -44.76%2.51M | -89.44%122.22K | -87.19%146.81K | -2.21%1.11M | 2.62%1.13M | 12.16%4.54M | 4.54%1.16M |
| Operating profit | -45.48%-4.07M | 36.45%-3.47M | 75.77%-2.25M | 28.65%-19.57M | 69.83%-2.01M | 61.40%-2.8M | 25.89%-5.46M | -57.63%-9.3M | 18.71%-27.43M | -8.84%-6.66M |
| Net non-operating interest income expense | -12.01%153.5K | -48.40%96.07K | -41.07%160.11K | 146.48%786.06K | -48.72%153.78K | 252.80%174.45K | 1,426.42%186.16K | 1,758.37%271.67K | 568.22%318.91K | 1,126.82%299.88K |
| Non-operating interest income | -5.86%163.87K | -43.91%104.42K | -36.65%172.52K | 113.84%786.36K | -48.74%153.79K | 165.76%174.07K | 8,293.28%186.16K | --272.34K | 28,362.46%367.74K | --300.02K |
| Non-operating interest expense | --10.37K | --8.36K | 1,761.17%12.41K | -99.39%299 | -91.11%12 | ---- | --0 | -95.93%667 | -29.66%48.82K | -99.54%135 |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---380 | ---- | ---- | ---- | ---- |
| Other net income (expense) | -106.41%-95.71K | 110.41%22.33K | 100.18%1.68K | 35.97%553.46K | -3.47%204.12K | 1,870.33%1.49M | 63.12%-214.5K | -304.58%-930.28K | 422.57%407.04K | 1,514.39%211.45K |
| Gain on sale of security | 79.14%-108.03K | -96.80%22.33K | 104.25%19.15K | -40.80%170.25K | 107.74%440.31K | -1,442.01%-517.98K | 220.04%698.1K | -221.02%-450.18K | 263.42%287.58K | 1,517.77%211.96K |
| Special income (charges) | --12.32K | --0 | 96.36%-17.48K | ---4.56M | ---236.19K | --0 | ---3.84M | ---480.1K | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --4.56M | ---- | ---- | ---- | ---- | --0 | --0 |
| -Less:Other special charges | ---12.32K | ---- | --17.48K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Write off | --0 | --0 | --0 | ---- | ---- | --0 | --3.84M | --480.1K | ---- | ---- |
| Other non- operating income (expenses) | ---- | ---- | ---- | 4,034.69%4.94M | --0 | 5,303.91%2.01M | --2.93M | ---- | 139.90%119.45K | ---506 |
| Income before tax | -254.96%-4.02M | 38.94%-3.35M | 79.00%-2.09M | 31.73%-18.23M | 73.14%-1.65M | 84.13%-1.13M | 31.07%-5.49M | -82.34%-9.96M | 21.32%-26.7M | 0.24%-6.15M |
| Income tax | ||||||||||
| Net income | -254.96%-4.02M | 38.94%-3.35M | 79.00%-2.09M | 22.77%-18.23M | 73.14%-1.65M | 84.13%-1.13M | -24.10%-5.49M | -68.62%-9.96M | 33.10%-23.61M | 3.14%-6.15M |
| Net income continuous Operations | -254.96%-4.02M | 38.94%-3.35M | 79.00%-2.09M | 31.73%-18.23M | 73.14%-1.65M | 84.13%-1.13M | 31.07%-5.49M | -82.34%-9.96M | 21.32%-26.7M | 0.24%-6.15M |
| Net income discontinuous operations | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 329.83%3.1M | --0 |
| Minority interest income | -163.67%-188.16K | -240.58K | -188.05K | -328.41K | -257.05K | -71.36K | 0 | 0 | 0 | |
| Net income attributable to the parent company | -261.11%-3.83M | 43.32%-3.11M | 80.89%-1.9M | 24.17%-17.9M | 77.32%-1.39M | 85.13%-1.06M | -24.10%-5.49M | -68.62%-9.96M | 33.10%-23.61M | 3.14%-6.15M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -261.11%-3.83M | 43.32%-3.11M | 80.89%-1.9M | 24.17%-17.9M | 77.32%-1.39M | 85.13%-1.06M | -24.10%-5.49M | -68.62%-9.96M | 33.10%-23.61M | 3.14%-6.15M |
| Basic earnings per share | -137.22%-4.1697 | 42.86%-5.2 | 80.77%-3.25 | 24.59%-29.9 | 72.63%-2.8469 | 85.77%-1.7577 | -16.67%-9.1 | -73.33%-16.9 | 39.60%-39.65 | -23.08%-10.4 |
| Diluted earnings per share | -137.22%-4.1697 | 42.86%-5.2 | 80.77%-3.25 | 24.59%-29.9 | 72.63%-2.8469 | 85.77%-1.7577 | -16.67%-9.1 | -73.33%-16.9 | 39.60%-39.65 | -23.08%-10.4 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data